GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for nucleoside-triphosphatase THEP1 (A2BL86)

Analyse AlphaFold monomer V2.0 prediction for nucleoside-triphosphatase THEP1 (A2BL86) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A2BL86
Type
protein
Length
187 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xa73BAb1DabE4333A884D03393eAa10c3B4215494
Molecule
Nucleoside-triphosphatase THEP1
UniProt
A2BL86
Pockets
1 · best druggability 0.46

Structure

1 distinct chain · 36% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANucleoside-triphosphatase THEP1protein18736% helix, 26% strandA2BL86

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11610.460.7629empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.